Allie Carew

PhD in Epidemiology and Applied Health Research

"I am excited to be conducting research that could help personalize type 2 diabetes treatment for heart disease prevention in such a welcoming and supportive department."

Past Education

  • Bachelor of Science (Honours) in Biology from Queen’s University
  • Master of Science in Community Health and Epidemiology from Dalhousie University

Why Dal and Community Health and Epidemiology?

I moved to Halifax in 2016 to pursue my master’s degree at Dalhousie University and fell in love with the city. Halifax has amazing restaurants, seaside hiking trails, a vibrant music scene, and warm and gentle people—what is not to love? I chose to do my PhD in the Department of Community Health and Epidemiology at Dalhousie University because I wanted to continue working with Dr. Cahill and Dr. Susan Kirkland (two highly regarded researchers in the department) in Halifax to develop a doctoral thesis that builds off my previous haptoglobin research while developing new areas of discovery and learning. I liked that the PhD in Epidemiology and Applied Health Research program offers a variety of learning experiences, including a diverse range of courses, a placement, professional development seminars, teaching and mentoring opportunities, and journal clubs, and would enable me to tailor my doctoral training to meet my research goals.

What inspires you?

My father passed away in 2014 at the age of 58 from complications of type 2 diabetes. Since then, I have been motivated to build a career in research that aims to identify factors that contribute to this disease and to determine which treatments help to prevent complications such as heart disease in people with type 2 diabetes.

Thesis Topic

I will be working with Dr. Leah Cahill and Dr. Susan Kirkland to study whether the simple and inexpensive once-in-a-lifetime haptoglobin phenotype biomarker should be implemented in type 2 diabetes treatment planning to personalize the appropriate intensity of blood glucose-lowering treatment to prevent cardiovascular disease.

Teaching and Research groups

  • Nourish Research Team

Publications

  • Carew AS, Mekary R, Mukamal K, Rimm EB, Ivey KL, Kirkland S, Urquhart R, Theou O, Blanchard C, Parkash R, Siddiqi F, Bennett M, Hu F, Cahill LE. Prospective study of skipping meals to lose weight as a predictor of incident type 2 diabetes with potential modification by cardiometabolic risk factors: the Canadian 1995 Nova Scotia Health Survey. Canadian Journal of Diabetes. 2020 Sep:S1499-2671(20).
  • Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, Byington R, Rimm EB, Sapp J, Gardner M, Cahill LE. Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes. Journal of the American College of Cardiology. 2020 Feb 3;75(5):512-21.

Presentations

  • Carew AS, Warren R, Kirkland S, Levy A, Selvin E, Sapp J, Woodward M, Cahill LE. Determining if implementation of the haptoglobin phenotype biomarker should be tested in type 2 diabetes treatment planning to prevent cardiovascular disease: a biostatistical analysis. 2021 Dalhousie University Department of Medicine Research Day, Halifax, NS. (Poster Presentation)
  • Carew AS, Warren R, Kirkland S, Levy A, Selvin E, Sapp J, Woodward M, Cahill LE. Should a simple blood test be included in type 2 diabetes treatment planning to prevent heart disease? 2021 Dalhousie University Department of Community Health and Epidemiology Research Day, Halifax, NS. (Oral Presentation)
  • Loung C, Sarfaraz S, Carew AS, MacKay D, Cahill LE. Bestselling nutrition books in Canada: author expertise, scientific evidence citations, and financial incentives. 2021 Dalhousie University Department of Medicine Research Day, Halifax, NS. (Oral Presentation)
  • Carew AS, Mekary R, Mukamal K, Rimm EB, Ivey KL, Kirkland S, Urquhart R, Theou O, Blanchard C, Parkash R, Siddiqi F, Bennett M, Hu F, Cahill LE. Prospective study of skipping meals to lose weight as a predictor of incident type 2 diabetes and coronary heart disease: the Canadian 1995 Nova Scotia Health Survey. 2020 American Heart Association Epi Lifestyle Scientific Sessions, Phoenix, AZ, USA. (Poster Presentation)
  • Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, Byington R, Rimm EB, Sapp J, Gardner M, Cahill LE. A simple blood test may help guide the intensity of treatment for type 2 diabetes. 2020 Libin International Trainee Symposium: Research is Better with Sex and Gender, Banff, AB. (Oral Presentation)
  • Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, Byington R, Rimm EB, Sapp J, Gardner M, Cahill LE. Haptoglobin phenotype modifies the influence of intensive glycemic control on cardiovascular outcomes. 2020 Dalhousie University Cardiac Research Day, Halifax, NS. (Poster Presentation)
  • Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, Byington R, Rimm EB, Sapp J, Gardner M, Cahill LE. Haptoglobin phenotype predicts cardiovascular disease and mortality within the ACCORD trial of intensive glycemic control. 2019 Dalhousie University Department of Medicine Research Day, Halifax, NS. (Oral Presentation)
  • Carew AS, Dodds L, Kuhle S, Kirkland S, Woolcott C. Is Gestational Diabetes Mellitus Associated with Future Cardiovascular Disease?. 2018 Diabetes Canada/Canadian Society of Endocrinology and Metabolism Professional Conference, Halifax, NS. (Oral Presentation)

Awards and Scholarships

  • Nova Scotia Graduate Scholarship
  • Best Research Fellow/Graduate Student Presentation, 2019 Dalhousie University Department of Medicine Research Day
  • IWK Graduate Studentship, IWK Health Centre
  • Loran Award, Loran Scholars Foundation
  • Chernoff Family Award, Queen’s University